41 studies found for:    " August 25, 2009":" September 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Enrolling by invitation Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Keep It Up!;   Behavioral: Information only
2 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
3 Completed Profile of HIV Seropositive Patients
Conditions: HIV Infection;   HIV Infections
Intervention:
4 Active, not recruiting TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
Conditions: HIV Infections;   HIV-1
Intervention: Drug: Etravirine
5 Completed Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
Conditions: HIV Prevention;   HIV Infections
Interventions: Drug: Tenofovir;   Drug: HEC Placebo;   Drug: Open label tenofovir tablet
6 Completed Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
7 Unknown  Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Drug: lopinavir/ritonavir plus maraviroc
8 Completed Mentor Mothers: A Sustainable Family Intervention in South African Townships
Conditions: Human Immunodeficiency Virus;   Acquired Immune Deficiency Syndrome;   Tuberculosis
Intervention: Behavioral: Peer support and mentoring
9 Completed Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
Conditions: HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: control group
10 Recruiting Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia;   Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Childhood Acute Lymphoblastic Leukemia;   B-cell Chronic Lymphocytic Leukemia;   Blastic Phase Chronic Myelogenous Leukemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Burkitt Lymphoma;   Childhood Chronic Myelogenous Leukemia;   Childhood Diffuse Large Cell Lymphoma;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Myelodysplastic Syndromes;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Chronic Myelomonocytic Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   Cutaneous B-cell Non-Hodgkin Lymphoma;   de Novo Myelodysplastic Syndromes;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   HIV Infection;   HIV-associated Hodgkin Lymphoma;   Intraocular Lymphoma;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Previously Treated Myelodysplastic Syndromes;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Grade III Lymphomatoid Granulomatosis;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Relapsing Chronic Myelogenous Leukemia;   Secondary Myelodysplastic Syndromes;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   T-cell Adult Acute Lymphoblastic Leukemia;   T-cell Childhood Acute Lymphoblastic Leukemia;   T-cell Large Granular Lymphocyte Leukemia;   Testicular Lymphoma;   Waldenström Macroglobulinemia
Interventions: Procedure: leukapheresis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Other: laboratory biomarker analysis
11 Unknown  HIV-discordant Couple Intrauterine Insemination
Conditions: Infertility;   HIV Infections
Interventions: Other: Sperm washing and testing for HIV contamination;   Procedure: Intrauterine Insemination
12 Completed HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: LPV/r + 2 NRTIs;   Drug: NVP or EFV + 2 NRTIs
13 Completed The St. Marys and The Mater Switch Study
Condition: HIV Infections
Intervention: Drug: Maraviroc
14 Completed Trial Embedded in an Electronic Personal Medical Health Records
Conditions: HIV Infections;   Health Literacy
Interventions: Other: Online access to a personal health record;   Other: No access to the PHR
15 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa
Condition: HIV Infections
Interventions: Drug: FTC/TDF;   Drug: Placebo
16 Completed CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Lopinavir/Ritonavir plus Lamivudine/Zidovudine;   Drug: Efavirenz plus Lamivudine/Zidovudine
17 Unknown  The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 3;   Drug: Fuzheng 1;   Drug: Placebo
18 Unknown  Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 2;   Drug: Placebo
19 Unknown  Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 1;   Drug: Placebo
20 Completed Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: mefloquine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years